Becton, Dickinson and Company (BIT:1BDX)

Market Cap	45.19B
Revenue (ttm)	19.31B
Net Income (ttm)	1.39B
Shares Out	n/a
EPS (ttm)	4.78
PE Ratio	32.61
Forward PE	12.37
Dividend	3.67 (2.44%)
Ex-Dividend Date	Mar 7, 2025

Volume	50
Average Volume	30
Open	152.00
Previous Close	150.75
Day's Range	152.00 - 155.95
52-Week Range	145.80 - 241.50
Beta	n/a
RSI	30.45
Earnings Date	May 1, 2025

About BIT:1BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 74,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1BDX

Financial Performance

In 2024, BIT:1BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.

Financial numbers in USD